Synapse - Stephanie Yvonne Fox

Stephanie Yvonne Fox

Research Focus

Former Employee. Research and Technology Management; Clinical Research Manager

Recent additions – View all

Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
Journal Article

Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Cadzin, B. R.; Fox, S. Y.; Gerecitano, J.; more...
Blood (2017)

Fulltext@MSK | Save
Baseline metabolic tumor volume is an independent prognostic factor for relapsed and refractory Hodgkin lymphoma patients receiving PET-adapted salvage therapy with brentuximab vedotin and augmented ICE
Meeting Abstract

Moskowitz, A. J.; Schöder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; more...
Hematological Oncology (2017)

Fulltext@MSK | Save
PET-adapted therapy with brentuximab vedotin and augmented ICE for relapsed/refractory Hodgkin lymphoma - Lack of Improvement with 3 versus 2 cycles of weekly brentuximab vedotin
Meeting Abstract

Moskowitz, A. J.; Schöder, H.; Yahalom, J.; McCall, S. J.; Fox, S. Y.; Gerecitano, J.; Grewal, R.; Hamlin, P. A.; Horwitz, S.; Kobos, R.; more...
Haematologica (2016)

Fulltext@MSK | Save

Co-authors at MSK

5

McCall
5

Moskowitz
5

Moskowitz
5

Schoder
5

Yahalom
4

Gerecitano
4

Grewal
4

Hamlin
4

Horwitz
4

Kumar
4

Matasar
4

Noy
4

Palomba
4

Perales
4

Portlock
4

Sauter
4

Straus
4

Younes
4

Zelenetz
3

Fleisher
2

Kobos
2

Ni
2

Shukla
2

Steinherz
2

Thoren
2

Trippett
1

Cadzin
1

Cho
1

Woo
1

Zhang

Types of Work

Publications